Pulmonary Vol. III
Three topics, 25 cases — choose one below to browse its cases.
Nontuberculous mycobacterial lung disease treatment thresholds and regimen design (MAC, M. abscessus), chronic suppressive and airway-clearance therapy in non-CF bronchiectasis, NTM treatment in cystic fibrosis on CFTR modulators, and aspiration pneumonitis versus pneumonia antibiotic decisions
Antifibrotic therapy selection and initiation thresholds in IPF and progressive pulmonary fibrosis, immunosuppression choice in connective-tissue-disease-associated ILD, treatment strategy in sarcoidosis and hypersensitivity pneumonitis, and steroid and antacid decisions in IPF management
Targeted-therapy resistance sequencing in EGFR- and KRAS-driven NSCLC, perioperative and first-line systemic therapy decisions, somatostatin analog selection in bronchial carcinoid, and paraneoplastic syndrome management in lung cancer